The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_005249.5(FOXG1):c.131A>C (p.His44Pro)

CA389474457

449126 (ClinVar)

Gene: FOXG1
Condition: FOXG1 disorder
Inheritance Mode: Autosomal dominant inheritance
UUID: afe54daf-e61f-4752-a1c8-8e90376e414f
Approved on: 2025-06-25
Published on: 2025-06-30

HGVS expressions

NM_005249.5:c.131A>C
NM_005249.5(FOXG1):c.131A>C (p.His44Pro)
NC_000014.9:g.28767410A>C
CM000676.2:g.28767410A>C
NC_000014.8:g.29236616A>C
CM000676.1:g.29236616A>C
NC_000014.7:g.28306367A>C
NG_009367.1:g.5330A>C
ENST00000706482.1:c.131A>C
ENST00000313071.7:c.131A>C
ENST00000313071.6:c.131A>C
NM_005249.4:c.131A>C
More

Likely Benign

Met criteria codes 2
BP4 BS2_Supporting
Not Met criteria codes 3
BS1 PS4 PM2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Rett and Angelman-like Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for FOXG1 Version 4.1.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The highest population minor allele frequency of the p.His44Pro variant in FOXG1 in gnomAD v4.1 is 0.00002649 in the Non-Finnish European population (not sufficient to meet BS1 criteria). The p.His44Pro variant is observed in at least 1 unaffected individual (Internal database - Ambry Genetics) (BS2_Supporting). The computational predictor REVEL gives a score of 0.041, which is below the threshold of 0.290, evidence that does not predict a damaging effect on FOXG1 function (BP4). In summary, the p.His44Pro variant in FOXG1 is classified as likely benign based on the ACMG/AMP criteria (BS2_Supporting, BP4). (FOXG1 Specifications v.4.1; curation approved on [06/25/2025])
Met criteria codes
BP4
The computational predictor REVEL gives a score of 0.041, which is below the threshold of 0.290, evidence that does not predict a damaging effect on FOXG1 function (BP4).
BS2_Supporting
The p.His44Pro variant is observed in at least 1 unaffected individual (Internal database - Ambry Genetics) (BS2_Supporting).
Not Met criteria codes
BS1
The highest population minor allele frequency of the p.His44Pro variant in FOXG1 in gnomAD v4.1 is 0.00002649 in the Non-Finnish European population (not sufficient to meet BS1 criteria).
PS4
This variant is not rare and is present in gnomAD.
PM2
gnomAD v4.1 - 28 alleles, MAF (ENF) 0.00002649
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.